Big name celebrities like Mandy Moore, Brooke Shields and Marisa Tomei attended a Hollywood charity event last March to launch the Latisse Wishes campaign – a charitable cause to support the Make-A-Wish foundation and generate interest in the new eyelash enhancement drug.
Latisse is Allergan’s latest offering and the first drug to be approved by the FDA for the treatment of hypotrichosis, a condition characterized by inadequate eyelashes. The Latisse Wishes campaign was launched by Allergan with a $500,000 initial contribution to Make-A-Wish.
Hollywood beauty expert and participant Anastasia Soare enthusiastically expressed her support, saying “I constantly work to help make women’s beauty wishes come true, and now we can help children’s wishes come true through the LATISSE™ Wishes campaign.”
It’s no coincidence that the Make-A-Wish foundation was chosen as a beneficiary for Allergan’s campaign; the superstitious “blowing on an eyelash to make a wish come true” provides a clever marketing strategy, backed by philanthropy.
The campaign is encouraging consumers to help double the donation amount by visiting www.Latisse.com and registering their support. From now until the end of the year, Allergan will donate 5 dollars for each new registration, up to one million dollars.
Latisse is now available at our office in Eugene, Oregon; give us a call for more information.
